Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer

Figure 3 Analysis of 3-year overall survival and 3-year disease-free survival, by different lymphocyte-to-monocyte ratios between emergency surgery and bridge to surgery groups. P < 0.05 (log-rank test). Low lymphocyte-to-monocyte ratio (LMR) (LMR < 1.67) indicated higher rates of 3-year OS (A) (HR = 0.40, 95%CI: 0.18-0.92, P = 0.031) and 3-year disease-free survival (DFS) (C) (HR = 0.42, 95%CI: 0.17-1.07, P = 0.068) in the bridge to surgery (BTS) group. Conversely, high LMR (LMR ≥ 1.67) showed lower proportions of 3-year OS (B) (HR = 4.32, 95%CI: 1.27-14.82, P = 0.019) and 3-year DFS (D) (HR = 2.72, 95%CI: 0.97-7.65, P = 0.058) in the BTS group.